Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration

Ward, Kathleen; McCormick, Sean D.; Sulkowski, Mark S.; Latkin, Carl A.; Chander, Geetanjali; Falade‐Nwulia, Oluwaseun

doi:10.1016/j.drugpo.2020.103019

Cited by 11 publications

(22 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two studies examined participant experiences with screening or testing for HCV as their primary objective (10,15), while two others looked at the whole care contiuum, from screening to treatment and monitoring (14,8) (Table 2). The remaining studies looked at experiences of participants in speci c testing programs (13,16) or speci c modes of testing delivery such as community-based outreach, point-of-care testing, and social network interventions (9,12,11). Common barriers and enablers were seen across all studies (Table 3).…”

Section: Resultsmentioning

confidence: 99%

“…After screening titles and abstracts, 50 studies were selected for full-text screening. Nine studies ful lled the eligibility criteria and were included (8,9,10,11,12,13,14,13).…”

Section: Resultsmentioning

confidence: 99%

“…The paper by Ward et al (11) 13) also noted a barrier to be concerns about interferon treatment, which was a poorly tolerated therapy with low e cacy. To ghi et al( 14) noted the limited awareness of the availability of Direct Acting Antiviral (DAA) therapy as a much better tolerated and highly e cacious treatment to be a barrier.…”

Section: Limited Awareness Of New Treatment Optionsmentioning

confidence: 99%

“…Ward et al noted that utilizing social networks could help to increase awareness of HCV testing since there was an overwhelming willingness of the participants to discuss HCV testing and treatment in their social networks with people whom they may not know well but have injected drugs with. Many of the participants felt comfortable discussing HCV and many had already had conversations with network members about HCV (11). One participant stated:…”

Section: Enablers To Testingmentioning

confidence: 99%

“…The majority of the participants in each study were male with the exception of Skeer et al (8) which had an equal representation from male and females. Most of the studies had a majority white population with the exception of Ward et al(11) and To ghi et al(14).…”

mentioning

confidence: 99%

See 4 more Smart Citations

Barriers and Enablers to Testing for Hepatitis C Infection in People Who Inject Drugs – A Scoping Review of the Qualitative Evidence

Balsom

Farrell

Kelly

2023

Preprint

View full text Add to dashboard Cite

Background Injection drug use is the primary mode of transmission of hepatitis C virus (HCV) infection in the developed world and guidelines recommend screening individuals with current or history of injection drug use for HCV; however, the majority of those living with HCV in Canada are not aware of their positive status. This low level of HCV status awareness suggests that screening is not effective with current testing strategies. The aim of this review is to determine what barriers and enablers people who inject drugs (PWID) experience surrounding testing for HCV to help inform the development of an appealing testing strategy. Methods Comprehensive literature searches were conducted using Medline, Embase and CINAHL. Included studies investigated the barriers and enablers to testing for HCV in PWID and the experiences of PWID in testing for HCV. Studies were included if they involved people with current injection drug use or those with a history of injecting drugs, were written in the English language and set in the community. Studies were compared and common themes were coded and analyzed Results Nine studies were included most studies focused on barriers instead of enablers. Common barriers included self-perception of low risk for HCV, fear of diagnosis, stigma associated with IV drug use and HCV, antipathy in relation to mainstream health care services, limited knowledge about HCV, lack of rapport with provider, lack of motivation or competing priority of drug use, and limited awareness of new treatment options. Common enablers to testing included increasing awareness of HCV testing and treatment and providing positive narratives around HCV care, positive rapport with provider, accessible testing options and personalized care. Conclusion This scoping review determined that there has been some research in this area over the past decade though it has not been focused to specifically address this research question. Nevertheless, some common barriers and enablers to testing for HCV were observed across the available research.

show abstract

Section: Resultsmentioning

confidence: 99%

“…After screening titles and abstracts, 50 studies were selected for full-text screening. Nine studies ful lled the eligibility criteria and were included (8,9,10,11,12,13,14,13).…”

Section: Resultsmentioning

confidence: 99%

Section: Limited Awareness Of New Treatment Optionsmentioning

confidence: 99%

Section: Enablers To Testingmentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations